Sign in
4

Changes in Ownership

AIM ImmunoTech Inc. Filed Acc 0001702626-19-000005

Chief Science/Medical Officer bought 2,481 shares at $4.03 ($9,998)

From the SEC's structured data for this filing

Trades in this filing

STRAYER DAVID R · Chief Science/Medical Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2019-06-21 Purchase : show line 1 in the form +2,481 $4.03 $9,998 5,420 D
Open-market purchases · 2,481 sh · avg $4.03 · $9,998
Loading xslF345X03/primary_doc.xml…